Kavya Deshpande

Stock Analyst at UBS

(1.16)
# 3,665
Out of 4,486 analysts
47
Total ratings
58.3%
Success rate
-2.2%
Average return

Stocks Rated by Kavya Deshpande

bioMérieux S.A.
Jun 1, 2026
Downgraded: Hold
Price Target: €138.00€80.00
Current: $70.25
Upside: +13.88%
Demant A/S
May 21, 2026
Reiterated: Buy
Price Target: $42
Current: $40.23
Upside: +3.90%
DiaSorin S.p.A.
Apr 9, 2026
Downgraded: Hold
Price Target: €84.00€66.00
Current: $68.38
Upside: -3.48%
Vimian Group AB (publ)
Feb 17, 2026
Maintained: Hold
Price Target: kr 34.00kr 30.00
Current: $31.00
Upside: -3.23%
Elekta AB (publ)
Sep 3, 2025
Initiated Coverage: Sell
Price Target: kr 34.00
Current: $52.60
Upside: -35.36%